Vident Advisory, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Vident Advisory, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.06 - $1.67 $18,142 - $28,583	-17,116 Reduced 13.32%	111,425 $129 Million
Q4 2023 Feb 14, 2024	SELL	$1.26 - $1.79 $14,457 - $20,538	-11,474 Reduced 8.19%	128,541 $217 Million
Q3 2023 Feb 21, 2024	BUY	$1.61 - $2.54 $18,473 - $29,143	11,474 Added 8.93%	140,015 $253 Million
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $225,424 - $355,638	140,015 New	140,015 $253 Million

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Advisory, LLC with notifications on news.